Koutoukas P - Search Results

1

Role of soluble triggering receptor expressed on myeloid cells in inflammatory bowel disease.

Tzivras M, Koussoulas V, Giamarellos-Bourboulis EJ, Tzivras D, Tsaganos T, Koutoukas P, Giamarellou H, Archimandritis A. Tzivras M, et al. Among authors: koutoukas p. World J Gastroenterol. 2006 Jun 7;12(21):3416-9. doi: 10.3748/wjg.v12.i21.3416. World J Gastroenterol. 2006. PMID: 16733861 Free PMC article.

2

Soluble triggering receptor expressed on myeloid cells 1 as an anti-inflammatory mediator in sepsis.

Giamarellos-Bourboulis EJ, Zakynthinos S, Baziaka F, Papadomichelakis E, Virtzili S, Koutoukas P, Armaganidis A, Giamarellou H, Roussos C. Giamarellos-Bourboulis EJ, et al. Among authors: koutoukas p. Intensive Care Med. 2006 Feb;32(2):237-243. doi: 10.1007/s00134-005-0017-1. Epub 2006 Feb 1. Intensive Care Med. 2006. PMID: 16450102

3

Evidence for the participation of soluble triggering receptor expressed on myeloid cells-1 in the systemic inflammatory response syndrome after multiple trauma.

Giamarellos-Bourboulis EJ, Mouktaroudi M, Tsaganos T, Koutoukas P, Spyridaki E, Pelekanou A, Kotzampassi K. Giamarellos-Bourboulis EJ, et al. Among authors: koutoukas p. J Trauma. 2008 Dec;65(6):1385-90. doi: 10.1097/TA.0b013e31814699cc. J Trauma. 2008. PMID: 19077631

4

Early apoptosis of monocytes contributes to the pathogenesis of systemic inflammatory response and of bacterial translocation in an experimental model of multiple trauma.

Efstathopoulos N, Tsaganos T, Giamarellos-Bourboulis EJ, Kaldis P, Nicolaou V, Papalois A, Koutoukas P, Papachristou G, Giamarellou H. Efstathopoulos N, et al. Among authors: koutoukas p. Clin Exp Immunol. 2006 Jul;145(1):139-46. doi: 10.1111/j.1365-2249.2006.03112.x. Clin Exp Immunol. 2006. PMID: 16792684 Free PMC article.

5

Indication for a role of regulatory T cells for the advent of influenza A (H1N1)-related pneumonia.

Raftogiannis M, Antonopoulou A, Baziaka F, Spyridaki A, Koutoukas P, Tsaganos T, Savva A, Pistiki A, Georgitsi M, Giamarellos-Bourboulis EJ. Raftogiannis M, et al. Among authors: koutoukas p. Clin Exp Immunol. 2010 Sep;161(3):576-83. doi: 10.1111/j.1365-2249.2010.04208.x. Clin Exp Immunol. 2010. PMID: 20646008 Free PMC article.

6

Clarithromycin co-administered with amikacin attenuates systemic inflammation in experimental sepsis with Escherichia coli.

Giamarellos-Bourboulis EJ, Baziaka F, Antonopoulou A, Koutoukas P, Kousoulas V, Sabracos L, Panagou C, Perrea D, Giamarellou H. Giamarellos-Bourboulis EJ, et al. Among authors: koutoukas p. Int J Antimicrob Agents. 2005 Feb;25(2):168-72. doi: 10.1016/j.ijantimicag.2004.08.018. Int J Antimicrob Agents. 2005. PMID: 15664488

7

Clarithromycin: immunomodulatory therapy of experimental sepsis and acute pyelonephritis by Escherichia coli.

Giamarellos-Bourboulis E, Adamis T, Sabracos L, Raftogiannis M, Baziaka F, Tsaganos T, Koutoukas P, Plachouras D, Karayannacos P, Giamarellou H. Giamarellos-Bourboulis E, et al. Among authors: koutoukas p. Scand J Infect Dis. 2005;37(1):48-54. doi: 10.1080/00365540510026832. Scand J Infect Dis. 2005. PMID: 15764190

8

Clarithromycin is an effective immunomodulator when administered late in experimental pyelonephritis by multidrug-resistant Pseudomonas aeruginosa.

Giamarellos-Bourboulis EJ, Antonopoulou A, Raftogiannis M, Koutoukas P, Tsaganos T, Tziortzioti V, Panagou C, Adamis T, Giamarellou H. Giamarellos-Bourboulis EJ, et al. Among authors: koutoukas p. BMC Infect Dis. 2006 Feb 21;6:31. doi: 10.1186/1471-2334-6-31. BMC Infect Dis. 2006. PMID: 16504031 Free PMC article.

9

Soluble urokinase plasminogen activator receptor (suPAR) for assessment of disease severity in ventilator-associated pneumonia and sepsis.

Savva A, Raftogiannis M, Baziaka F, Routsi C, Antonopoulou A, Koutoukas P, Tsaganos T, Kotanidou A, Apostolidou E, Giamarellos-Bourboulis EJ, Dimopoulos G. Savva A, et al. Among authors: koutoukas p. J Infect. 2011 Nov;63(5):344-50. doi: 10.1016/j.jinf.2011.07.016. Epub 2011 Aug 3. J Infect. 2011. PMID: 21839112

10

Early apoptosis of blood monocytes is a determinant of survival in experimental sepsis by multi-drug-resistant Pseudomonas aeruginosa.

Antonopoulou A, Raftogiannis M, Giamarellos-Bourboulis EJ, Koutoukas P, Sabracos L, Mouktaroudi M, Adamis T, Tzepi I, Giamarellou H, Douzinas EE. Antonopoulou A, et al. Among authors: koutoukas p. Clin Exp Immunol. 2007 Jul;149(1):103-8. doi: 10.1111/j.1365-2249.2007.03392.x. Epub 2007 May 4. Clin Exp Immunol. 2007. PMID: 17488299 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27 results

Search Page

Filters